HOME › DRUGS › INFIGRATINIB
ACTIVE SUBSTANCE / INN

INFIGRATINIB

Brand name(s): Febseltiq
EMA LISTED
APPLICATION WITHDRAWN
Cholangiocarcinoma
ACTIVE SUBSTANCE
Infigratinib
REGULATORS
EMA
SPONSORS / MAH
Helsinn Birex Pharmaceuticals Ltd
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
FebseltiqHelsinn Birex Pharmaceuticals LtdApplication withdrawnCholangiocarcinoma

FULL INTELLIGENCE ON INFIGRATINIB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →